Dr. Reddy’s因原料杂质暂停仿制Ozempic供应
2026-07-09 15:06:55
据彭博社报道，印度瑞迪博士实验室因在部分批次关键原料中发现未知杂质，已暂停其仿制Ozempic药物的商业化生产，至少停至10月，并下调首年生产目标。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Next article：
地缘政治 | 以色列防长：已准备好攻击伊朗
